A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency
Clinical trial NCT06432140 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06432140
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2026-07-23
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.